• Explore /
  • Poster
  • / ARTISTRY-1: Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors.

ARTISTRY-1: Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors.

Abstract Video & Slides Poster

Authors

null

Valentina Boni

START Madrid CIOCC Madrid, Madrid, Spain

Valentina Boni , Ira Seth Winer , Lucy Gilbert , Ulka N. Vaishampayan , Seth David Rosen , Jameel Muzaffar , Anna Spreafico , David F. McDermott , Quincy S. Chu , Olivier Dumas , Aman Chauhan , Arvind Chaudhry , Piotr Tomczak, MD , Debora S. Bruno , Yangchun Du , Ilda Bidollari , Jessicca Martin Rege , Marc S. Ernstoff , James F. Strauss , Vamsidhar Velcheti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

New Targets and New Technologies (IO)

Clinical Trial Registration Number

NCT02799095

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 2513)

DOI

10.1200/JCO.2021.39.15_suppl.2513

Abstract #

2513

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Genitourinary Cancers Symposium

Nemvaleukin alfa in patients with advanced renal cell carcinoma: ARTISTRY-1.

Nemvaleukin alfa in patients with advanced renal cell carcinoma: ARTISTRY-1.

First Author: Emiliano Calvo

First Author: Sarina Anne Piha-Paul

First Author: Ulka N. Vaishampayan

First Author: Thomas J. Herzog